COMMUNIQUÉS West-GlobeNewswire

Remix Therapeutics™ Appoints Michael Landsittel to Board of Directors
06/10/2026
WATERTOWN, Mass., Oct. 06, 2026 (GLOBE NEWSWIRE) -- Remix Therapeutics (Remix), Inc., a clinical-stage biotechnology company developing small molecule therapies to modulate RNA processing and address the underlying [...]
Community HealthCare Resources Launches Fall 2026 Clinician Recruitment Initiative
06/10/2026
Nationwide initiative invites healthcare professionals to expand access to care and explore Public Service Loan Forgiveness (PSLF) opportunities through CHR’s nonprofit model BETTENDORF, Iowa, Oct. 06, 2026 (GLOBE [...]
Ozari Health Launches Ozari One: Compounded Tirzepatide Online for $125 a Month, Same Price at Every Dose
06/10/2026
The LegitScript-certified telehealth platform's new plan bills $375 every three months for compounded tirzepatide with B12, filled by one of three named US-licensed 503A compounding pharmacies, with the provider visit [...]
Going Beyond Addiction
06/10/2026
San Diego-based Shoreline Recovery Center highlights the importance of long-term support for individuals following addiction treatment San Diego, CA., Oct. 06, 2026 (GLOBE NEWSWIRE) -- Achieving sobriety after addiction [...]
Fast Company Names Veyond Metaverse a 2026 Next Big Things in Tech Winner for OceanMD, XR Telemedicine for Ships and Remote Sites
06/10/2026
OceanMD brings a remote physician virtually beside the medic on ships and offshore sites where specialist help can be days away SAN FRANCISCO, Oct. 06, 2026 (GLOBE NEWSWIRE) -- Veyond Metaverse , a developer of [...]
MedSpa Board and QUAD A Provide Joint Guidance on IV Infusion Safety Following Recent Safety Concerns
06/10/2026
HIGHLAND PARK, Ill., Oct. 06, 2026 (GLOBE NEWSWIRE) -- Following recent FDA and CDC safety communications involving compounded injectable glutathione and related adverse events, QUAD A and MedSpa Board are providing [...]
Recognizing Warnings Before a Crisis
06/10/2026
San Diego-based Park Mental Health Treatment Center educates community on subtle signs that shouldn’t be ignored San Diego, CA., Oct. 06, 2026 (GLOBE NEWSWIRE) -- Every day, millions of people are fighting a battle to [...]
Blink Anesthesia, maker of the TwitchView® quantitative neuromuscular monitor, names Medtronic veteran Lindsay Boyle VP of Commercial Operations
06/10/2026
SEATTLE, Oct. 06, 2026 (GLOBE NEWSWIRE) -- Blink Anesthesia announced today that Lindsay Boyle, Ed.D., MBA joins the leadership team as VP of Commercial Operations, where she will lead sales, marketing, and commercial [...]
Nox Peptides Announces Launch of BPC-157 Research Product and Resources for Canadian Research Market
06/10/2026
TORONTO, Oct. 06, 2026 (GLOBE NEWSWIRE) -- Nox Peptides, a Canadian-based supplier of research compounds, today announced the launch of its BPC-157 research product and supporting research resources for laboratories, [...]
Jupiter Neurosciences Announces First Patient Dosed in Phase 2a RESET Trial in Parkinson’s Disease and Exploration of Strategic Options to Maximize Shareholder Value
06/10/2026
First Patient Dosed with JOTROL ™ Marks Major Clinical Milestone for Jupiter Neurosciences’ Phase 2a Study Evaluating Safety, Pharmacokinetics and Biomarkers of JOTROL ™ in Patients with Parkinson’s Disease Tungsten [...]
RAMSAY SANTE : résultats annuels définitifs à fin juin 2026
06/10/2026
COMMUNIQUÉ DE PRESSE Paris, 6 octobre 2026 Résultats annuels à fin juin 2026 Croissance du chiffre d’affaires et discipline financière contribuent à l’amélioration de la rentabilité opérationnelle Capital Markets Day du [...]
RAMSAY SANTE : Final annual results as of 30 June 2026
06/10/2026
PRESS RELEASE Paris, 6 th October 2026 Annual results at the end of June 2026 Revenue growth and disciplined efficiency drive stronger operational profitability Capital Markets Day on 17 th September: Ramsay Santé [...]
LB Pharmaceuticals to Host In-Person and Virtual R&D Day on October 27, 2026: Advancing LB‑102 with a Focus on Schizophrenia Treatment
06/10/2026
NEW YORK, Oct. 06, 2026 (GLOBE NEWSWIRE) -- LB Pharmaceuticals Inc (“LB Pharmaceuticals” or the “Company”) (Nasdaq: LBRX), a neuromedicines company dedicated to developing and commercializing high-impact therapies that [...]
Entera Appoints Global BioPharma Executive Laura Hamill to Its Board of Directors, Expanding Commercial Expertise
06/10/2026
Former Gilead and Amgen executive joins Entera with over 35 years of experience advancing and commercializing impactful and blockbuster therapies TEL AVIV, Israel, Oct. 06, 2026 (GLOBE NEWSWIRE) -- Entera Bio Ltd. ( [...]
YD Bio and EG BioMed Launch AI-Based 10-Cancer Risk Factor Assessment
06/10/2026
TAIPEI, Taiwan, and BOTHELL, Wash., Oct. 06, 2026 (GLOBE NEWSWIRE) -- YD Bio Limited (“YD Bio” or the “Company”) (Nasdaq: YDES), a biotechnology company advancing DNA methylation-based cancer detection technology and [...]
vTv Therapeutics to Host Virtual KOL Event on Hypoglycemia in Type 1 Diabetes and the Cadisegliatin Phase 3 Program on October 20, 2026
06/10/2026
HIGH POINT, N.C., Oct. 06, 2026 (GLOBE NEWSWIRE) -- vTv Therapeutics Inc. (Nasdaq: VTVT), a late-stage biopharmaceutical company advancing cadisegliatin, a novel oral investigational therapy for type 1 diabetes (T1D), [...]
Odyssey Therapeutics Announces Oral Presentation of Additional Phase 2a Induction Data for OD-001 in Ulcerative Colitis at UEG Week 2026
06/10/2026
Company to host conference call and webcast following the presentation on Tuesday, October 20, at 8:00 a.m. EDT BOSTON, Oct. 06, 2026 (GLOBE NEWSWIRE) -- Odyssey Therapeutics, Inc. (Nasdaq: ODTX) (“Odyssey” or the “ [...]
Oak Hill Bio Appoints Joerg Hipp, PhD as Chief Translational Science Officer
06/10/2026
CAMBRIDGE, Mass., Oct. 06, 2026 (GLOBE NEWSWIRE) -- OHB Pediatrics Ltd d/b/a Oak Hill Bio, a clinical-stage rare disease therapeutics company, today announced the appointment of Joerg Hipp, PhD as Chief Translational [...]
Telomir Pharmaceuticals Secures $5.6 Million Financing as Billionaire Entrepreneur John Paul DeJoria Increases Investment in the Company
06/10/2026
Common Stock PIPE Strengthens Telomir’s Capital Position as Company Advances Telomir-Zn into Clinical Development Under FDA-Cleared IND in Triple-Negative Breast Cancer (TNBC) MIAMI, Oct. 06, 2026 (GLOBE NEWSWIRE) -- [...]

Pages